Dr Geetha Govindasamy obtained her PhD from  Monash University, Australia, M.A from the International University of Japan, M.Phil from Queens' College, Cambridge University, UK.  She is an expert on  East Asian international relations. She teaches  courses related to East Asian regional affairs. Generally, she publishes more on inter-Korean issues and East Asian interactions. Her publications  can be found in the local and international journals, UM Press and other reputable publishers. Thus far, she has been a recipient of various research grants from Korea Foundation, Sumitomo Foundation and local funding.  Her networking experiences include academic exchanges at Hankuk University of Foreign Studies, Korea University, Institute of Far Easter Studies (IFES), Kyungnam University and the Graduate Institute, Geneva (IHEID).  Dr Govindasamy was also invited to attend the Study of the United States Institute (SUSI) Exchange programe for acadermics in 2013 and in 2019, she was invited by the  Ministry of Foreign Affairs, Japan to be part of an academic tour to Tokyo and Okinawa.  Dr Govindasamy is a member of  Malaysian Scholars on Korea (MASK) and  the Malaysia-Japan Association (MAJAS) and simultaneously is the  Managing Editor of Wilayah: International Journal of East Asian Studies. At present, she is a Senior Visiting Fellow at the Cambodian Institute for Peace and Cooperation.

ChM. Dr. Liew Sook Yee (MRSC) is a senior lecturer in Chemistry Division, Centre for Foundation Studies in Science, Universiti Malaya. She obtained a BSc from Universiti of Terengganu (UMT) in 2010 with first class honour and have been awarded “Anugerah Graduan Terbaik Keseluruhan Fakulti Sains dan Teknologi/Program Sarjana Muda Sains (Sains Kimia)”. Then, she directly pursued PhD study (fast track) with SLAI scholarship in UM and graduated in 2014. Her fields of expertise and specialization are Natural Product Chemistry, Medicinal Chemistry, Bioorganic Chemistry, Enzyme Inhibition and Kinetic studies. She has plenty of experience in isolating and purifying compounds as well as structural elucidation of compounds. She also developed her expertise in cutting-edge techniques which is 13C NMR-based dereplication in natural product studies. She is a member of Royal Chemistry of Society (UK) and Institut Kimia Malaysia as well as an associate member of CENAR (UM). Her research works are conducted in Phytolab (IFM NatProLab), Department of Chemistry, Faculty of Science and she welcomes all the collaborations from academician, scientist, researcher, company and etc.

Dr. Tan Ai Huey is an Associate Professor at the Faculty of Medicine, Universiti Malaya (UM) and Consultant Neurologist and Physician at the Universiti Malaya Medical Centre. As a clinician-scientist, she dedicates her career to excellence in patient care, and medical research and education, particularly in the neurological subspecialty area of Parkinson's disease (PD) and Movement Disorders. After completing her specialty training in Internal Medicine and subspecialty training in Neurology in 2015, Dr. Tan obtained a PhD degree (with thesis distinction), in which she explored the role of the gut microbiome and novel therapeutic approaches, such as probiotics, in PD. Leading an inter-disciplinary research team at UM, her research has since expanded to genetic and biomarker discoveries in PD and rare movement disorders (e.g., dystonia and ataxia), with the aim to uncover factors that are unique and relevant to the Asian population. Other key research areas include uncovering the impact of geriatric conditions, comorbidities, and non-motor features, as well as understanding patient/caregiver perspectives, in PD. Through collaborations with local and international partners, Dr. Tan and her team work tirelessly to advance personalized, holistic, and patient-centered care in PD and related disorders. Dr. Tan has published extensively in leading medical journals, including first-author publications in Nature Reviews Neurology, Annals of Neurology, Neurology, and Movement Disorders, and co-authorship publications in Lancet Neurology, Nature Genetics, and JAMA Neurology. Her research has received support from renowned funding organizations including the Michael J. Fox Foundation, Aligning Science Across Parkinson's (ASAP) via the Global Parkinson’s Genetic Program (GP2), and the Toray Science Foundation. She currently serves as an Associate Editor for Parkinsonism & Related Disorders, a reputable journal in the field. Dr. Tan was elected as President of the Malaysian Society of Neurosciences (MSN) from 2018 to 2022, the professional body that represents Malaysian neurologists and neuroscientists. She currently serves as the Chair of the MSN Movement Disorder Council, within which she co-authored the National Consensus Treatment Guidelines for PD. She has played key roles in developing the national neurology subspecialty training curriculum. Internationally, she was Treasurer of the ASEAN Neurological Association and has been appointed to Chair several committees of the International Parkinson & Movement Disorder Society (MDS, the world body representing clinicians and scientists in the PD/Movement Disorder field), including the MDS Communications Oversight Committee and the MDS Web-based Learning Subcommittee. She is also the Secretary-Elect of the MDS Asian-Oceanian Section Executive Committee and a member of the MDS Evidence-Based Medicine Steering Committee. Grateful for the mentors in her career, she is highly passionate about teaching and believes in developing the next-generation talent in medicine and science. She was twice voted Best Clinical Lecturer Award at the UM Faculty of Medicine. More recently, she won the University's Excellent Lecturer Award and the Yound Educator Award from the College of Physicians, Malaysia. Frequently invited as an expert faculty member at various national and international conferences and workshops, Dr. Tan is dedicated to enhancing education and training in PD and movement disorders, especially in underserved regions around the globe, where these efforts can have the most significant impact.